Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
Clinical trial NCT06732531 · RECRUITING
Trial details
- NCT number
- NCT06732531
- Sponsor
- Zhuhai Beihai Biotech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-03
- Primary completion
- 2025-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.